JOURNAL OF HIGH ENERGY PHYSICS, ISSN 1029-8479, 07/2016, Issue 8
Combined ATLAS and CMS measurements of the Higgs boson production and decay rates, as well as constraints on its couplings to vector bosons and fermions, are...
CERN LHC | Higgs physics | CROSS-SECTIONS | HADRON COLLIDERS | Hadron-Hadron scattering (experiments) | SEARCH | NLO QCD CORRECTIONS | TRANSVERSE-MOMENTUM | STANDARD MODEL | BROKEN SYMMETRIES | QUARKS | TO-LEADING ORDER | PHYSICS, PARTICLES & FIELDS | Fysik | Physical Sciences | Naturvetenskap | Natural Sciences
CERN LHC | Higgs physics | CROSS-SECTIONS | HADRON COLLIDERS | Hadron-Hadron scattering (experiments) | SEARCH | NLO QCD CORRECTIONS | TRANSVERSE-MOMENTUM | STANDARD MODEL | BROKEN SYMMETRIES | QUARKS | TO-LEADING ORDER | PHYSICS, PARTICLES & FIELDS | Fysik | Physical Sciences | Naturvetenskap | Natural Sciences
Journal Article
JAMA, ISSN 0098-7484, 01/2006, Volume 295, Issue 2, pp. 180 - 189
CONTEXT Atherothrombosis is the leading cause of cardiovascular morbidity and mortality around the globe. To date, no single international database has...
GLOBAL BURDEN | MEDICINE, GENERAL & INTERNAL | MANAGEMENT | QUALITY | WAIST CIRCUMFERENCE | MYOCARDIAL-INFARCTION | OVERWEIGHT | ATHEROSCLEROSIS | BODY-MASS INDEX | ACUTE CORONARY SYNDROMES | BMI | Prevalence | Global Health | Humans | Middle Aged | Risk Factors | Cardiovascular Diseases - therapy | Male | Thrombosis - epidemiology | Atherosclerosis - epidemiology | Drug Utilization | Outpatients | Atherosclerosis - therapy | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Cardiovascular Diseases - epidemiology | Female | Registries | Aged | Platelet Aggregation Inhibitors - therapeutic use | Thrombosis - therapy | Care and treatment | Atheroembolism | Cardiovascular diseases | Risk factors | Blood vessels | Cardiovascular disease | Medical treatment
GLOBAL BURDEN | MEDICINE, GENERAL & INTERNAL | MANAGEMENT | QUALITY | WAIST CIRCUMFERENCE | MYOCARDIAL-INFARCTION | OVERWEIGHT | ATHEROSCLEROSIS | BODY-MASS INDEX | ACUTE CORONARY SYNDROMES | BMI | Prevalence | Global Health | Humans | Middle Aged | Risk Factors | Cardiovascular Diseases - therapy | Male | Thrombosis - epidemiology | Atherosclerosis - epidemiology | Drug Utilization | Outpatients | Atherosclerosis - therapy | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Cardiovascular Diseases - epidemiology | Female | Registries | Aged | Platelet Aggregation Inhibitors - therapeutic use | Thrombosis - therapy | Care and treatment | Atheroembolism | Cardiovascular diseases | Risk factors | Blood vessels | Cardiovascular disease | Medical treatment
Journal Article
PHYSICAL REVIEW LETTERS, ISSN 0031-9007, 05/2015, Volume 114, Issue 19
A measurement of the Higgs boson mass is presented based on the combined data samples of the ATLAS and CMS experiments at the CERN LHC in the H -> gamma gamma...
PHYSICS, MULTIDISCIPLINARY | BROKEN SYMMETRIES | GAUGE | Fysik | Physical Sciences | Naturvetenskap | Natural Sciences
PHYSICS, MULTIDISCIPLINARY | BROKEN SYMMETRIES | GAUGE | Fysik | Physical Sciences | Naturvetenskap | Natural Sciences
Journal Article
Heart, ISSN 1355-6037, 02/2017, Volume 103, Issue 4, pp. 307 - 314
ObjectiveWe studied evolving antithrombotic therapy patterns in patients with newly diagnosed non-valvular atrial fibrillation (AF) and ≥1 additional stroke...
CARDIAC & CARDIOVASCULAR SYSTEMS | THERAPY | STROKE PREVENTION | RISK-FACTOR | WARFARIN | TRANSIENT ISCHEMIC ATTACK | GLOBAL ANTICOAGULANT REGISTRY | GUIDELINES | EURO HEART SURVEY | SUBGROUP ANALYSIS | THROMBOEMBOLISM | Prospective Studies | Age Factors | Humans | Middle Aged | Stroke - diagnosis | Male | Fibrinolytic Agents - adverse effects | Time Factors | Aged, 80 and over | Female | Registries | Stroke - epidemiology | Atrial Fibrillation - diagnosis | Stroke - prevention & control | Risk Assessment | Administration, Oral | Atrial Fibrillation - drug therapy | Comorbidity | Risk Factors | Treatment Outcome | Practice Patterns, Physicians' - trends | Guideline Adherence | Atrial Fibrillation - epidemiology | Sex Factors | Aged | Fibrinolytic Agents - administration & dosage | Practice Guidelines as Topic | Stroke (Disease) | Care and treatment | Usage | Atrial fibrillation | Diagnosis | Thrombolytic drugs | Patients | Health aspects | Risk factors | Arrhythmias and Sudden Death | 1506 | Stroke
CARDIAC & CARDIOVASCULAR SYSTEMS | THERAPY | STROKE PREVENTION | RISK-FACTOR | WARFARIN | TRANSIENT ISCHEMIC ATTACK | GLOBAL ANTICOAGULANT REGISTRY | GUIDELINES | EURO HEART SURVEY | SUBGROUP ANALYSIS | THROMBOEMBOLISM | Prospective Studies | Age Factors | Humans | Middle Aged | Stroke - diagnosis | Male | Fibrinolytic Agents - adverse effects | Time Factors | Aged, 80 and over | Female | Registries | Stroke - epidemiology | Atrial Fibrillation - diagnosis | Stroke - prevention & control | Risk Assessment | Administration, Oral | Atrial Fibrillation - drug therapy | Comorbidity | Risk Factors | Treatment Outcome | Practice Patterns, Physicians' - trends | Guideline Adherence | Atrial Fibrillation - epidemiology | Sex Factors | Aged | Fibrinolytic Agents - administration & dosage | Practice Guidelines as Topic | Stroke (Disease) | Care and treatment | Usage | Atrial fibrillation | Diagnosis | Thrombolytic drugs | Patients | Health aspects | Risk factors | Arrhythmias and Sudden Death | 1506 | Stroke
Journal Article
European Heart Journal, ISSN 0195-668X, 10/2016, Volume 37, Issue 38, pp. 2882 - 2889A
The relationship between outcomes and time after diagnosis for patients with non-valvular atrial fibrillation (NVAF) is poorly defined, especially beyond the...
Stroke prevention | Stroke | Anticoagulation | Atrial fibrillation | Bleeding | MORTALITY | CARDIAC & CARDIOVASCULAR SYSTEMS | HEART-FAILURE | PREVENTION | DEATH | PREVALENCE | RISK STRATIFICATION SCHEMES | ANTITHROMBOTIC TREATMENT | RHYTHM MANAGEMENT | REGISTRY | Clinical Research
Stroke prevention | Stroke | Anticoagulation | Atrial fibrillation | Bleeding | MORTALITY | CARDIAC & CARDIOVASCULAR SYSTEMS | HEART-FAILURE | PREVENTION | DEATH | PREVALENCE | RISK STRATIFICATION SCHEMES | ANTITHROMBOTIC TREATMENT | RHYTHM MANAGEMENT | REGISTRY | Clinical Research
Journal Article
JOURNAL OF HIGH ENERGY PHYSICS, ISSN 1029-8479, 05/2019, Issue 5
This paper presents the combinations of single-top-quark production cross-section measurements by the ATLAS and CMS Collaborations, using data from LHC...
PARTON DISTRIBUTIONS | EVENTS | Hadron-Hadron scattering (experiments) | MISSING MOMENTUM | RECONSTRUCTION | LHC | COLLISIONS | LIKELIHOOD METHOD | PHYSICS, PARTICLES & FIELDS | Fysik | Physical Sciences | Naturvetenskap | Natural Sciences
PARTON DISTRIBUTIONS | EVENTS | Hadron-Hadron scattering (experiments) | MISSING MOMENTUM | RECONSTRUCTION | LHC | COLLISIONS | LIKELIHOOD METHOD | PHYSICS, PARTICLES & FIELDS | Fysik | Physical Sciences | Naturvetenskap | Natural Sciences
Journal Article
Age and Ageing, ISSN 0002-0729, 7/2011, Volume 40, Issue 4, pp. 423 - 429
Background: the European Working Group on Sarcopenia in Older People has developed a clinical definition of sarcopenia based on low muscle mass and reduced...
Measurement | Sarcopenia | Grip strength | Protocol | Elderly | PINCH STRENGTH | MORTALITY | METAANALYSIS | elderly | PHYSICAL CAPABILITY | RELIABILITY | HAND STRENGTH | ELBOW | measurement | REFERENCE VALUES | GERIATRICS & GERONTOLOGY | POSITION | protocol | grip strength | sarcopenia | Severity of Illness Index | Muscle Strength Dynamometer - standards | Predictive Value of Tests | Reproducibility of Results | Prognosis | Age Factors | Humans | Sarcopenia - diagnosis | Equipment Design | Sarcopenia - epidemiology | Sarcopenia - physiopathology | Aging | Geriatric Assessment - methods | Aged | Hand Strength | Observer Variation | Physiological aspects | Standards | Clinical trials | Older people | Geriatrics
Measurement | Sarcopenia | Grip strength | Protocol | Elderly | PINCH STRENGTH | MORTALITY | METAANALYSIS | elderly | PHYSICAL CAPABILITY | RELIABILITY | HAND STRENGTH | ELBOW | measurement | REFERENCE VALUES | GERIATRICS & GERONTOLOGY | POSITION | protocol | grip strength | sarcopenia | Severity of Illness Index | Muscle Strength Dynamometer - standards | Predictive Value of Tests | Reproducibility of Results | Prognosis | Age Factors | Humans | Sarcopenia - diagnosis | Equipment Design | Sarcopenia - epidemiology | Sarcopenia - physiopathology | Aging | Geriatric Assessment - methods | Aged | Hand Strength | Observer Variation | Physiological aspects | Standards | Clinical trials | Older people | Geriatrics
Journal Article
Physics Letters B, ISSN 0370-2693, 09/2012, Volume 716, Issue 1, pp. 1 - 29
A search for the Standard Model Higgs boson in proton–proton collisions with the ATLAS detector at the LHC is presented. The datasets used correspond to...
TRANSVERSE-MOMENTUM | BROKEN SYMMETRIES | PARTON DISTRIBUTIONS | MASSES | DECAY | ASTRONOMY & ASTROPHYSICS | QCD CORRECTIONS | TAU | PHYSICS, NUCLEAR | COLLIDERS | PHYSICS, PARTICLES & FIELDS | Collisions (Nuclear physics) | Analysis | Standards | Detectors | Searching | Decay | Elementary particles | Higgs bosons | Standard deviation | Channels | Physics - High Energy Physics - Experiment | Physics | High Energy Physics - Experiment | PHYSICS OF ELEMENTARY PARTICLES AND FIELDS | Qcd Corrections | Hadron Colliders | Transverse-Momentum | Massless Particles | Gauge Fields | Proton-Proton Collisions | Fysik | Broken Symmetries | Physical Sciences | Naturvetenskap | Parton Distributions | Root-S=7 Tev | Natural Sciences | Cross-Sections
TRANSVERSE-MOMENTUM | BROKEN SYMMETRIES | PARTON DISTRIBUTIONS | MASSES | DECAY | ASTRONOMY & ASTROPHYSICS | QCD CORRECTIONS | TAU | PHYSICS, NUCLEAR | COLLIDERS | PHYSICS, PARTICLES & FIELDS | Collisions (Nuclear physics) | Analysis | Standards | Detectors | Searching | Decay | Elementary particles | Higgs bosons | Standard deviation | Channels | Physics - High Energy Physics - Experiment | Physics | High Energy Physics - Experiment | PHYSICS OF ELEMENTARY PARTICLES AND FIELDS | Qcd Corrections | Hadron Colliders | Transverse-Momentum | Massless Particles | Gauge Fields | Proton-Proton Collisions | Fysik | Broken Symmetries | Physical Sciences | Naturvetenskap | Parton Distributions | Root-S=7 Tev | Natural Sciences | Cross-Sections
Journal Article
PLOS ONE, ISSN 1932-6203, 10/2016, Volume 11, Issue 10, p. e0164076
Aims Vitamin K antagonists (VKAs) need to be individually dosed. International guidelines recommend a target range of international normalised ratio (INR) of...
STROKE | MORTALITY | MANAGEMENT | SCORE | MULTIDISCIPLINARY SCIENCES | ANTITHROMBOTIC THERAPY | INTENSITY | RISK | ANTICOAGULATION | Antiplatyhelmintic Agents - administration & dosage | Antiplatyhelmintic Agents - therapeutic use | Stroke - prevention & control | Prospective Studies | Anticoagulants - administration & dosage | Hemorrhage - epidemiology | Atrial Fibrillation - drug therapy | Humans | Middle Aged | Risk Factors | Anticoagulants - therapeutic use | Male | Treatment Outcome | Anticoagulants - adverse effects | International Normalized Ratio | Vitamin K - antagonists & inhibitors | Atrial Fibrillation - mortality | Female | Registries |
STROKE | MORTALITY | MANAGEMENT | SCORE | MULTIDISCIPLINARY SCIENCES | ANTITHROMBOTIC THERAPY | INTENSITY | RISK | ANTICOAGULATION | Antiplatyhelmintic Agents - administration & dosage | Antiplatyhelmintic Agents - therapeutic use | Stroke - prevention & control | Prospective Studies | Anticoagulants - administration & dosage | Hemorrhage - epidemiology | Atrial Fibrillation - drug therapy | Humans | Middle Aged | Risk Factors | Anticoagulants - therapeutic use | Male | Treatment Outcome | Anticoagulants - adverse effects | International Normalized Ratio | Vitamin K - antagonists & inhibitors | Atrial Fibrillation - mortality | Female | Registries |